Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.

Santini E, Cuccato S, Madec S, Chimenti D, Ferrannini E, Solini A.

Endocrinology. 2009 Jun;150(6):2596-602. doi: 10.1210/en.2008-1486. Epub 2009 Feb 5.

PMID:
19196799
2.

Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures.

Caraccio N, Cuccato S, Pratesi F, Dardano A, Ursino S, Chimenti D, Boldrini L, Materazzi G, Migliorini P, Monzani F.

Thyroid. 2009 Feb;19(2):149-55. doi: 10.1089/thy.2008.0290.

PMID:
19191746
3.

Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.

Solini A, Santini E, Madec S, Cuccato S, Ferrannini E.

Growth Factors. 2007 Dec;25(6):392-9. doi: 10.1080/08977190801892341.

PMID:
18365870
4.

Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?

Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di Virgilio F, Monzani F.

Endocrinology. 2008 Jan;149(1):389-96. Epub 2007 Oct 18.

PMID:
17947359
5.

Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.

Solini A, Santini E, Madec S, Nannipieri M, Bonotti A, Cuccato S, Ferrannini E.

Diabetes Metab Res Rev. 2008 Mar-Apr;24(3):197-204.

PMID:
17922475
6.

Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4.

Solini A, Santini E, Chimenti D, Chiozzi P, Pratesi F, Cuccato S, Falzoni S, Lupi R, Ferrannini E, Pugliese G, Di Virgilio F.

Am J Physiol Renal Physiol. 2007 May;292(5):F1537-47. Epub 2007 Jan 30.

7.

Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors.

Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani C, Di Virgilio F, Ferrannini E, Solini A.

Endocrinology. 2005 Jul;146(7):3172-8. Epub 2005 Mar 24.

PMID:
15790728
8.

Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.

Caraccio N, Giannini R, Cuccato S, Faviana P, Berti P, Galleri D, Dardano A, Basolo F, Ferrannini E, Monzani F.

J Clin Endocrinol Metab. 2005 Feb;90(2):1156-62. Epub 2004 Nov 23.

PMID:
15562032
9.

Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.

Tortora G, Caputo R, Damiano V, Bianco R, Fontanini G, Cuccato S, De Placido S, Bianco AR, Ciardiello F.

Clin Cancer Res. 2001 Aug;7(8):2537-44.

10.

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, De Placido S, Bianco AR, Tortora G.

Clin Cancer Res. 2001 May;7(5):1459-65.

11.

RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.

Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P, Romeo G, Corvi R.

Cytogenet Cell Genet. 2000;88(1-2):56-61.

PMID:
10773666

Supplemental Content

Loading ...
Support Center